COLUMBUS, Ohio, July 23 (Nationwide Times) — For people trying to make sense of the latest nutrition headlines, the main point is simple: a specially made tomato-soy drink lowered three inflammation-related proteins in a small study of adults with obesity. The finding is interesting, but it does not mean grocery-store tomato juice has the same effect, and it does not amount to a new treatment recommendation.
What the study tested
Researchers reported the results in Molecular Nutrition & Food Research, and the study is indexed in PubMed. The trial involved 12 adults with obesity. Each person drank two 6-ounce servings a day for four weeks, then went through a washout period before switching in a crossover design.
The drink was not standard tomato juice. According to the study abstract, it was made from tomatoes bred to contain high levels of lycopene, a red plant compound found in tomatoes, and it was fortified with soy isoflavones. The control drink was a low-carotenoid tomato juice.
What changed
After the tomato-soy drink, the researchers reported significant decreases in IL-5, IL-12p70 and GM-CSF. These are cytokines, or immune signaling proteins, that help cells communicate during inflammation.
The study also found that TNF-alpha trended downward, but the change did not meet conventional statistical significance. Plasma lycopene increased 2.48-fold after the tomato-soy beverage, showing that the intervention changed blood levels of the tomato compound. The researchers also reported shared changes in the urine metabolome, suggesting some tomato-related effects that were not explained by lycopene alone.
What it means for a normal reader
The study points to a possible anti-inflammatory effect from a specific experimental beverage, not from ordinary tomato juice. That matters because the formula was specially designed and the trial was very small. With only 12 participants, the study is too limited to show long-term health benefits or to support broad dietary advice.
In other words, the research is a clue for scientists, not a green light to treat tomato juice as medicine. It also does not show whether the blood-marker changes would translate into fewer symptoms, fewer doctor visits or lower disease risk over time.
Has tomato juice been studied before?
This was not the first study to look at tomato products and inflammation. A separate randomized study published in 2013 and indexed in PubMed found that tomato juice lowered some inflammatory markers in overweight or obese female students at Tehran University of Medical Sciences. In that trial, IL-8 and TNF-alpha fell in the intervention group, and IL-6 dropped in obese participants.
The two studies are different and should not be combined into one result. Taken together, they suggest tomato-based drinks may influence inflammation-related markers, but the evidence is still early and narrow.
